A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study
Michael A. Nauck(Diabeteszentrum Bad Lauterberg), S. Duran(Hospital Universitario de Valme), D. Kim, Don Johns(Eli Lilly (United States)), Justin Northrup(Eli Lilly (United States)), Andreas Festa, Robert G. Brodows(Eli Lilly (United States)), Michael Trautmann
Cited by 440Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis